To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.

Notwithstanding any other provision of the law, amounts authorized to be appropriated or otherwise available for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024 may not exceed $50,000,000.